Latest news
Pharvaris (NASDAQ:PHVS) Sets New 12-Month High - What's Next? - MarketBeatMarketBeat · Fri, 07 Aug 2026 14:11:35 GMTPainful swelling and misdiagnoses disrupted daily life in Pharvaris study - Stock TitanStock Titan · Thu, 06 Aug 2026 10:50:00 GMTPharvaris: One Molecule Could Reshape Both Sides Of HAE Treatment (NASDAQ:PHVS) - Seeking AlphaSeeking Alpha · Tue, 04 Aug 2026 15:04:03 GMT(PHVS) Risk Channels and Responsive Allocation - Stock Traders DailyStock Traders Daily · Sun, 02 Aug 2026 00:54:02 GMTPharvaris N.V. (PHVS) investor LSP V trims stake to 4.9% of shares - Stock TitanStock Titan · Fri, 31 Jul 2026 11:23:11 GMTPharvaris NV (PHVS) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKeyTradingKey · Mon, 27 Jul 2026 05:38:21 GMTPHVS|Pharvaris NV|Price:34.300|Chg%:+0.880 - TradingKeyTradingKey · Sun, 26 Jul 2026 14:42:20 GMT